RenovoRx (NASDAQ:RNXT) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of RenovoRx (NASDAQ:RNXT – Free Report) to a sell rating in a report issued on Friday. A number of other brokerages have also recently issued reports on RNXT. Ascendiant Capital Markets upped their price objective on RenovoRx from $11.00 to $11.50 and gave the stock a “buy” rating in a […]
Wall Street Zen upgraded shares of RenovoRx (NASDAQ:RNXT – Free Report) to a sell rating in a report issued on Friday. A number of other brokerages have also recently issued reports on RNXT. Ascendiant Capital Markets upped their price objective on RenovoRx from $11.00 to $11.50 and gave the stock a “buy” rating in a […]
